MDxHealth SA (MDXH) Reports Q2 Loss, Tops Revenue Estimates
MDxHealth SA (MDXH) delivered earnings and revenue surprises of -15.38% and +0.02%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead...
Was macht MDxHealth?
Unternehmensprofil
MDxHealth SA is a commercial-stage precision diagnostics company, which engages in the development and commercialization of molecular diagnostic products for personalized cancer treatment. It operates through the following geographical segments: United States of America, The Netherlands, Belgium, Spain, Poland, Italy, Rest of EU, and Rest of the World. The firm offers ConfirmMDx, SelectMDx, AssureMDx, InformMDx, SelectMDx, and MonitorMDx. The company was founded by Herman Spolders and Philip S. Devine on January 10, 2003 and is headquartered in Herstal, Belgium.
Chart der MDxHealth Aktie
Charttool öffnen
Aktuelle Nachrichten zu MDxHealth
Weitere Nachrichten
Das berichten andere über MDxHealth
Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
IRVINE, CA, and HERSTAL, BELGIUM – July 3, 2025 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the "Company" or "mdxhealth"), a leading precision diagnostics company,...
MDxHealth SA (MDXH) Q1 2025 Earnings Call Transcript
MDxHealth SA (MDXH) Reports Q1 Loss, Tops Revenue Estimates
MDxHealth SA (MDXH) delivered earnings and revenue surprises of -46.15% and 0.76%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead...
Wir finden für unsere Leser softwaregestützt die besten Aktien der Welt
und schreiben darüber, wie man diese handeln muss, um Geld zu verdienen.